Alkem Labs Receives GST Demand Order of ₹7.89 Lakhs, Plans Appeal
Alkem Laboratories received a GST demand order for FY21-22, totaling ₹7,89,834/- plus ₹6,02,958/- interest and ₹78,984/- penalty. The company disputes the 'excess availment of Input Tax Credit' allegation and plans to appeal. No material financial impact is anticipated.
The company explicitly stated that there is no material impact on its financial, operational, or other activities. The demand amount is also relatively small in the context of the company's overall financials.
The company received a GST demand order, which is a negative event. However, the amount is not material, and the company intends to contest it, indicating a neutral overall sentiment.
Alkem Laboratories Limited has announced that it has received an order from the State Tax Officer, Ghatak 55 (Bharuch), Gujarat, concerning Goods and Services Tax (GST).
The order pertains to the financial year 2021-2022 and demands GST amounting to ₹7,89,834/-, along with interest of ₹6,02,958/- and a penalty of ₹78,984/-. The demand order primarily alleges excess availment of Input Tax Credit.
The company stated that it does not agree with the demand order and intends to contest it by filing an appeal. The order was received on December 29th, 2025. Alkem Laboratories Limited has indicated that there is no material impact on its financial, operational, or other activities resulting from this order.
What to do with a filing like this
Alkem Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under regulatory impact. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Alkem Laboratories Limited. Read the original for the full detail.